Market position and operating model
Kivo provides cloud regulatory document, content, process, submission-planning, dossier, and correspondence management for emerging life-sciences sponsors and service providers.
Kivo is included because smaller regulatory teams need a distinct evaluation path from global enterprise RIM and may prioritize controlled content and submission readiness over extensive master-data functionality.
The primary classification describes where Kivo begins in the buyer's operating problem. It does not imply that every module, jurisdiction, workflow, integration, service, or data dependency is interchangeable with another organization in the same category. Buyers should confirm the exact product, edition, service boundary, and accountable party included in a proposal.
Who should evaluate Kivo
Emerging pharmaceutical, biotechnology, and device teams seeking controlled regulatory content, collaboration, submission preparation, and implementation support without a large enterprise RIM program.
The reviewed record names or supports these market segments: Pharmaceutical, Biotechnology, Medical Device, Contract Research Organization. Segment positioning is useful for scoping diligence, but it does not establish configuration fit, regulatory applicability, implementation capacity, or customer outcome.
A strong evaluation begins with a real scenario and its exception path. Ask the organization to identify inputs, authoritative content, configured rules, decision owners, handoffs, evidence retained, exports available, and the behavior when required data is missing or contradictory.
Documented capability record
| Capability | Evidence state | What remains to verify |
|---|---|---|
| Controlled Documents Open provider-specific evidence record → | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Computerized-System Validation Support Open provider-specific evidence record → | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Regulatory Activity And Commitment Tracking Open provider-specific evidence record → | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Submission Planning And Dossier Management | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Health-Authority Correspondence | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
Known evidence limits
Kivo states that publishing is handed off to specialist tools or services; buyers should not infer native eCTD publishing. Public pages do not establish full global registration management, enterprise scale, or a customer's validated state.
A documented capability means a current official source supports relevant positioning. It is not an independent observation of configured behavior, accuracy, completeness, latency, usability, implementation effort, integration depth, support quality, customer outcome, or legal and regulatory fitness. Missing public evidence remains not established; it is not silently converted into feature absent.
Enterprise demonstration agenda
- Confirm the precise product, edition, service, geography, and customer population under evaluation.
- Trace one representative case from intake through decision, exception, evidence retention, reporting, and downstream exchange.
- Repeat the workflow with missing data, a conflicting rule or record, a changed authority source, and a user override.
- Identify which content, interpretation, configuration, integration, review, approval, and validation responsibilities remain with the customer or another party.
- Export the decision history and reconcile it to the governing source, configured version, user action, timestamps, and affected records.
Questions to take into diligence
- Which named workflows and capabilities are available in the proposed package today?
- Which authority, content, data, or network dependencies are maintained by the provider, a partner, or the customer?
- How are changes detected, assessed, tested, approved, released, and preserved historically?
- What implementation roles, controlled configurations, integrations, migrations, and ongoing services are required?
- What can an auditor, regulator, clinical reviewer, compliance owner, or operational leader reconstruct from the exported record?
Source and research record
The dossier uses 11 normalized record elements and 1 linked evidence records internally. Those operational totals are not presented as a quality score. The decision-relevant public record is the claim, its source, evidence class, scope, and limitation.
- Kivo Regulatory Information Managementofficial provider product page · monitored monthly